🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Staples Sector SEC Filings — September 04, 2026

The single filing in this digest is a Form 4 insider transaction report from Mondelez International, Inc., revealing that EVP & COO Zaramella Luca exercised 22,570 stock options at $43.20 and concurrently had 18,695 shares withheld for taxes at $62.45, resulting in a net increase of approximately 3,875 shares. The transaction is routine and neutral in sentiment, reflecting standard option exercise and tax withholding mechanics rather than a directional signal on management conviction. With only one filing, portfolio-level trend analysis is limited, but the exercise price ($43.20) versus current market price ($62.45) indicates a 44.6% appreciation since grant, suggesting strong long-term value creation. The lack of open-market purchases or sales, combined with the modest net share increase, points to a stable insider posture. Investors should monitor upcoming earnings calls and any forward guidance for broader sector signals, as this filing alone provides limited actionable intelligence.

1 high priority 1 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 04, 2026

The six filings from the S&P 500 Industrials stream reveal a sector characterized by steady capital returns and insider activity that is largely neutral or tax-driven, with no major operational surprises. Paychex stands out with strong fiscal 2026 performance—service revenue up 16% YoY to $6.3B and operating income up 14% YoY—but a mixed sentiment emerges from executive compensation shortfalls (cash incentives at only 64% of target) and no vested performance equity, signaling potential governance or goal-setting misalignment. Insider transactions at Automatic Data Processing, Otis Worldwide, and Union Pacific are low-materiality and routine (plan sales, tax withholdings, gifts), suggesting no strong conviction signals. General Dynamics' filing is a passive institutional disclosure with no actionable insight. Overall, the sector shows resilience in revenue growth and shareholder returns (Paychex raised dividends 10% and repurchased $611M), but the lack of forward guidance or major catalysts across most filings limits near-term alpha opportunities. Investors should monitor Paychex's October 2026 annual meeting for shareholder proposal outcomes and watch for any operational updates from the other names.

5 high priority 1 medium 6 total filings
· daily

US Material Events SEC 8-K Filings — September 04, 2026

The September 4, 2026, filing cycle reveals a market dominated by transformative M&A and restructuring, with several high-conviction deals closing. The most significant event is SoundHound AI's acquisition of LivePerson, creating a debt-free conversational AI giant targeting over $500M in revenue from an existing Fortune 100 customer base, a clear [BULLISH] signal for the AI sector. Concurrently, Flex Ltd. announced a $4.4 billion acquisition of EPC Power to capture AI data center demand, alongside plans to spin off its Cloud and Power Infrastructure segment, signaling a strategic pivot. On the negative side, a wave of auditor resignations and going-concern warnings (Regenerex Pharma, Katapult) and a high-risk, short-term bridge loan (Stewards, Inc.) highlight acute financial distress among smaller caps. The period also saw significant insider activity with a large inducement grant for a key executive at Helix Energy Solutions, and a notable reduction in authorized shares at LivePerson, confirming the going-private nature of the deal. Overall, the digest points to a bifurcated market where well-capitalized firms are aggressively consolidating for growth, while others face existential liquidity crises.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 04, 2026

Today's insider trading digest reveals a market characterized by aggressive option exercises and equity awards at Protalix BioTherapeutics, contrasting with significant open-market selling at Borr Drilling and Sea Ltd. A notable cluster of director share disposals to the issuer at LivePerson Inc. signals potential corporate restructuring or capital management. While bullish insider buying is limited, the purchases by the CEO of 17 Education & Technology Group and the COO of Charlotte's Web Holdings suggest management conviction in undervalued turnaround stories. The most significant capital movement is a $4.2M sale by a 10% owner at PBF Energy, which, combined with multiple Rule 10b5-1 plan sales, points to a cautious outlook from key stakeholders in the energy and tech sectors. Overall, the data shows a bifurcated market where insider sentiment is heavily skewed toward neutral events like option awards, but the few open-market transactions lean bearish, particularly in cyclical and high-growth sectors. The lack of forward-looking guidance in these filings limits catalyst calendar building, but the patterns of insider selling at recent highs warrant close monitoring for potential downside pressure.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 04, 2026

The five filings from Dow 30 constituents reveal a period of significant insider activity, with two high-materiality sell transactions from senior executives at Johnson & Johnson and Salesforce, signaling potential caution at the top. While no forward-looking guidance or period-over-period financial comparisons were provided in these specific filings, the insider trading patterns are the dominant theme. The largest transaction is a $6.19M sale by J&J's MedTech Chair, which is partially offset by concurrent option exercises, suggesting a planned liquidity event rather than a pure bearish signal. Salesforce's Director sale of $803K contrasts with the company's new deferred compensation plan, which is a neutral administrative move. Nvidia's Director gifted 500,000 shares under a 10b5-1 plan, a non-cash event that does not reflect a change in outlook. The absence of any bullish insider buying or positive capital allocation signals (dividends, buybacks) across the cohort creates a cautious undertone for the broader Dow 30, suggesting a period of management recalibration rather than aggressive optimism.

5 high priority 5 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 04, 2026

The September 4, 2026, corporate distress landscape is dominated by a cluster of Nasdaq and NYSE American noncompliance events, with 5 of 7 filings involving delisting risks from equity, bid price, or public float deficiencies. A notable trend is the severe equity erosion across micro-cap biotech and tech firms: Arcadia Biosciences reported just $633K in equity (vs. $2.5M minimum), Quince Therapeutics posted negative equity of -$35.3M (vs. $10M minimum), and Matinas BioPharma fell to $1.8M (vs. $2.0M minimum). The only positive signal is RE/MAX Holdings' going-private merger completion, which removed a distressed public company from the market. Insider activity is absent across all filings, suggesting management teams are either unable or unwilling to signal confidence through purchases. The aggregate forward-looking data reveals a critical catalyst calendar: 4 companies face compliance plan submission deadlines by October 15, 2026, creating a compressed window for restructuring or capital raises.

7 high priority 7 total filings
· daily

Global High-Priority Regulatory Events — September 04, 2026

The 38 filings for September 4, 2026, reveal a market landscape dominated by corporate restructuring, delistings, and strategic M&A, particularly within the SPAC and small-cap space. A significant cluster of companies are facing Nasdaq non-compliance, with **SCWorx Corp.**, **Arcadia Biosciences**, **Quince Therapeutics**, and **Pantages Capital** all receiving deficiency notices, highlighting acute financial distress and elevated delisting risk across micro-cap equities. The completion of major acquisitions, including **SoundHound AI's** purchase of **LivePerson** and the merger of **USA Rare Earth** with **Serra Verde**, signals a consolidation trend in high-growth tech and critical minerals sectors. Insider activity is limited in the filings, but capital allocation decisions, such as **VineBrook Homes Trust's** tender offer at a 37.4% discount to NAV and **Monroe Capital's** oversubscribed buyback, provide key signals on management's view of intrinsic value. The period-over-period data from **Hemadri Cements** shows a dramatic operational shutdown (zero revenue vs. ₹794.62 Lakh YoY), while the **Archer Aviation** warrant expiration on September 16 creates a time-sensitive catalyst for warrant holders. Overall, the digest points to a bifurcated market where well-capitalized acquirers are consolidating, while a growing number of smaller entities face existential threats from listing standards and liquidity crises.

38 high priority 38 total filings
· daily

US SEC Filings Daily Market Digest — September 04, 2026

Today's digest reveals a market bifurcated between aggressive corporate restructuring and cautious capital management. The most significant development is Flex Ltd.'s $4.4 billion acquisition of EPC Power, coupled with plans to spin off its Cloud and Power Infrastructure segment, signaling a major bet on AI data center infrastructure. This is contrasted by multiple distress signals: Nixxy, Inc. received a Nasdaq deficiency notice, ClearOne faces a going concern risk with only $0.7M cash, and Rent the Runway agreed to a $9M class action settlement. On the positive side, Ionis Pharmaceuticals received FDA approval for ZANVASTRO, the first treatment for Alexander disease, while ChargePoint showed operational improvement with revenue up 17.7% YoY and a narrowed net loss. Insider activity was mixed, with NatWest executives conducting routine sales and Sea Ltd's COO selling $1.22M in shares under a 10b5-1 plan. Capital allocation trends show a preference for M&A and spin-offs over buybacks, with News Corp being a notable exception with its ongoing $1B repurchase program. The overall theme is one of strategic pivots and financial prudence, with significant opportunities in biotech and AI infrastructure, but elevated risks in SPACs and pre-revenue companies.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 04, 2026

The single filing analyzed for the S&P 500 Consumer Discretionary stream on September 4, 2026, is from DoorDash, Inc., revealing a concentrated insider selling event by Director Tang Stanley. Despite a prior acquisition of 30,835 shares, the director executed a net sale of approximately 15,522 shares at $226.52, totaling ~$3.52 million, under a Rule 10b5-1 plan. The overall sentiment is negative with a materiality score of 7/10, signaling potential caution at the board level. No period-over-period trends, forward-looking guidance, capital allocation changes, or transaction details were available for this filing, limiting the breadth of sector-wide insights. The key takeaway is a high-conviction insider sale that warrants close monitoring for further insider activity or upcoming earnings commentary.

1 high priority 1 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 04, 2026

The six filings are concentrated in three large healthcare companies—Elevance Health, Eli Lilly, and UnitedHealth Group—with all reported activity involving insider transactions rather than operating results, guidance, capital allocation, or M&A. The most material development is Johnson & Johnson MedTech executive Timothy Schmid's sale of 22,527 shares for approximately $6.19 million after option exercises and conversions; this is the only filing assigned negative sentiment and carries the highest materiality score of 7/10. Elevance Health reported tax-withholding transactions by two senior executives totaling 399 shares and approximately $164,500, while UnitedHealth CFO Wayne DeVeydt withheld 1,208.895 shares valued at approximately $483,000; these are generally administrative transactions and do not establish discretionary bearish conviction. Eli Lilly executives gifted 229 shares in aggregate, also a low-materiality activity with no clear directional signal. No period-over-period financial metrics, forward guidance, scheduled events, dividend or buyback data, transaction valuations, or financial-ratio trends were supplied, so no defensible cross-company growth, margin, valuation, or capital-allocation comparison can be made from this batch. The actionable distinction is between routine withholding/gifting activity and the substantially larger J&J MedTech disposition, which warrants monitoring but should not be treated as definitive evidence of deteriorating fundamentals without additional filings or operating disclosures.

6 high priority 6 total filings
· daily

US Earnings Financial Results SEC Filings — September 04, 2026

This batch of 24 filings reveals a market bifurcated between strong operational turnarounds and persistent cash-burn risks. Revenue growth is uneven, with standout performances from Snowflake (+35% YoY), Pure Storage (+37.8% YoY), and Victoria's Secret (+10.4% YoY), while several companies like Duluth Holdings (-7.8% YoY) and Virco Mfg (-5% YoY) face top-line pressure. A critical theme is aggressive capital allocation: share buybacks are surging at Abercrombie & Fitch ($286.4M in H1) and DocuSign ($625.3M in H1), often at the expense of cash reserves. Margin improvement is a key driver of earnings beats, with Victoria's Secret and Oxford Industries seeing gross margins expand significantly. However, the landscape is littered with high-risk micro-cap entities (Blue Chip Capital, Elite Performance) that are effectively insolvent, and several SPACs face mandatory liquidation deadlines. The most actionable insights come from comparing period-over-period trends in cash flow, insider activity, and forward guidance to separate genuine value creators from those masking structural issues with one-time gains.

24 high priority 24 total filings
· daily

US Executive Compensation Proxy SEC Filings — September 04, 2026

This digest of 11 pre-analyzed proxy filings reveals a bifurcated market landscape: while established firms like Paychex and Standex demonstrate robust financial health and disciplined capital returns, a cluster of smaller-cap companies (iBio, Grown Rogue, Jasper Therapeutics) are pursuing dilutive share increases or reverse splits, signaling distress. The most critical developments are two transformative M&A events—BioLife Solutions' acquisition by Repligen and Sanara MedTech's acquisition by MiMedx—both with materiality scores of 9-10/10 and shareholder votes imminent in late September. A notable trend across filings is the prevalence of 'mixed' sentiment (Paychex, Taylor Devices, Jasper, Sanara), where strong operational performance is offset by governance red flags like insider selling, missed bonus targets, or dilutive proposals. Insider activity data is sparse but revealing: Taylor Devices' CEO saw total comp drop 18% YoY, while Paychex's executives missed 36% of their target bonus, suggesting pay-for-performance discipline. The forward-looking catalyst calendar is dense, with five shareholder meetings scheduled between September 21 and October 26, 2026, creating near-term trading catalysts around M&A votes and governance decisions.

11 high priority 11 total filings
· daily

US IPO Pipeline SEC S-1 Filings — September 04, 2026

The September 4, 2026 IPO pipeline is dominated by three new S-1 registrations (Legion Capital Acquisition Corp., New Iceland Arctic Acquisition Corp., and ADARx Pharmaceuticals) and one S-4 for a SPAC merger (Churchill Capital Corp XI/Agility Robotics), alongside a high-risk IPO from Laser Photonics Corp. A clear bifurcation is emerging: cash-rich SPACs (New Iceland Arctic, $125M target) and biotech IPOs (ADARx) are pursuing high-growth narratives despite deep losses, while Laser Photonics offers a distressed, going-concern turnaround story. Period-over-period data reveals a stark divergence in financial health—ADARx's net loss widened 58% YoY to $73.1M, while Laser Photonics' revenue surged 144% YoY to $8.3M but losses exploded 600% to $17.5M. The most critical development is the Churchill Capital/Agility Robotics merger, which brings a high-profile robotics company to public markets via a SPAC, a structure that has faced significant headwinds. Portfolio-level patterns show a concentration of risk in pre-revenue biotech and cash-burning SPACs, with no insider trading activity disclosed in any filing, limiting conviction signals.

5 high priority 5 total filings
· daily

US SEC Trading Suspension Halt Orders — September 04, 2026

All six filings in this digest relate to US-listed companies facing trading suspensions or delisting risks, with a notable concentration in Nasdaq and NYSE American noncompliance notices. The primary theme is a wave of continued listing standard failures, driven by deteriorating balance sheets (negative or insufficient stockholders' equity) and share price declines. Five of the six companies (Nixxy, Arcadia, SCWorx, Matinas, Quince) have received deficiency notices, with SCWorx and Quince showing the most severe financial distress (public float 82% below minimum; equity $45M below threshold). Archer Aviation's warrant expiration is a scheduled event, not a financial distress signal, but it does create a specific trading catalyst. Across the group, there is a clear pattern of micro-cap biotech and tech companies struggling to maintain listing standards, with insider activity limited but notable in Nixxy (CFO appointment with equity incentives). The near-term catalyst calendar is dense, with compliance plan deadlines in mid-October 2026 for Arcadia and Quince, and a September 9, 2026 response deadline for SCWorx.

6 high priority 6 total filings
· daily

US Executive Officer Management Changes SEC — September 04, 2026

This digest covers 35 filings focused on executive and director changes, with the majority being routine departures and appointments. However, several filings contain material developments: The Bancorp's restructuring (9% workforce reduction, $14M annual savings) and Hooker Furnishings' governance failure (excess equity awards rescinded) are notable negative signals. Ategrity Specialty Insurance's significant executive compensation increase and Nordicus Partners' appointment of a highly experienced independent director are positive signals. A cluster of three BlackRock-affiliated funds (BlackRock Private Credit Fund, BlackRock Direct Lending Corp., BlackRock TCP Capital Corp.) all announced the simultaneous departure of Philip Tseng from multiple leadership roles, indicating a coordinated succession event. The overall theme is one of routine governance with isolated pockets of material change, particularly in the financial and industrial sectors.

35 high priority 35 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 04, 2026

The September 4, 2026 batch of 35 SEC filings reveals a significant wave of board and C-suite changes across US-listed companies, with a notable concentration of departures and retirements rather than new appointments. The most critical development is the coordinated leadership transition at three BlackRock-affiliated credit funds (TCPC, BDEBT, BDLC), where Philip Tseng resigned from all director and CEO roles effective August 31, 2026, with Jason Mehring and Dan Worrell stepping up across all three entities—a rare synchronized reshuffle that signals a strategic shift in BlackRock's private credit leadership. Another high-materiality event is The Bancorp's restructuring, which eliminates 9% of its workforce and exits small business lending, generating $14M in annualized savings but incurring $5.6M in charges. The period-over-period comparisons are limited as most filings lack financial data, but insider activity patterns emerge: no insider buying was reported, while multiple departures (COO at SmartKem, CFO at Co-Diagnostics, CAO at Harrow) occurred without immediate replacements, suggesting potential operational gaps. Forward-looking data reveals a catalyst calendar with several key dates: Rambus CAO transition (Sept 8), Helix/Hornbeck merger-related equity awards (vesting by 2029), and Crown Holdings GC retirement (Dec 31). The overall sentiment is predominantly neutral (32/35 filings), with only one positive (Ategrity's CEO retention) and one negative (Hooker Furnishings' equity award error), indicating a routine but active period of governance reshuffling with limited immediate market impact.

35 high priority 35 total filings
· daily

USA Insider Trading Pulse — September 04, 2026

The September 4, 2026, insider trading pulse reveals a mixed but cautious landscape. The most significant bearish signal comes from PBF Energy, where a 10% owner sold ~$7.7M in stock, representing the largest single-day insider outflow. This is compounded by a cluster of negative sentiment filings from Sea Ltd, where two C-suite officers sold over $1.3M combined under 10b5-1 plans, and from Borr Drilling, where three top executives sold a total of ~$270K at a low stock price of $4.80. On the bullish side, insider buying was concentrated in micro-cap and distressed names, with the CEO of 17 Education & Technology Group and the COO of Charlotte's Web Holdings making notable open-market purchases. A strong positive signal emerged from Taiwan Semiconductor Manufacturing Co (TSMC), where an SVP bought $77K in shares, signaling confidence from a key insider at the world's leading foundry. The day was dominated by neutral, non-discretionary events, including a massive equity grant cycle at Protalix BioTherapeutics (awarding ~500K options and RSUs to the entire board and CEO) and tax-withholding transactions at Elevance Health and One Stop Systems. The overall theme is one of insider caution in larger caps and selective, high-conviction buying in smaller, beaten-down names, with a notable absence of bullish insider activity in mid-to-large cap growth stocks.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 04, 2026

This digest covers 15 filings, with a heavy concentration of SPAC activity including IPOs, business combinations, extensions, and compliance issues. The most material M&A events are the completed acquisitions of LivePerson by SoundHound AI and FSC Bancshares by Hawthorn Bancshares, and the combination of USA Rare Earth with Serra Verde. A clear theme is the acceleration of SPAC deadlines and the emergence of post-merger execution risks, particularly for companies like LivePerson, which underwent a going-private transaction. Insider activity is limited, but the appointment of LivePerson's former CFO at SoundHound AI signals integration focus. Capital allocation trends show a shift toward debt-free balance sheets post-merger, while several SPACs face existential risks from Nasdaq non-compliance or going-concern qualifications. The period-over-period data reveals no revenue trends due to the nature of filings, but forward-looking statements from SoundHound AI and Hawthorn Bancshares provide actionable revenue and operational targets.

15 high priority 15 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 04, 2026

Overnight SEC filings from September 3-4, 2026, reveal a market bifurcated between high-conviction insider selling in growth/biotech names and significant corporate actions (M&A, spin-offs, restructurings). The most critical development is the FDA approval of Ionis Pharmaceuticals' ZANVASTRO for Alexander disease, a landmark event for an ultra-rare disorder, though offset by a mixed financial picture. A wave of insider selling, particularly at Natera, Spyre Therapeutics, and Takeda, signals potential near-term tops in these high-flying names. Activist pressure is building at TransAct Technologies, while corporate restructuring dominates headlines with Flex's spin-off and The Trade Desk's 15% workforce reduction. The IPO litigation settlement at Rent the Runway and the de-registration of RE/MAX highlight ongoing post-IPO and M&A fallout. Overall, the data suggests a cautious tone from corporate insiders, offset by significant strategic catalysts in biotech and energy.

39 high priority 11 medium 50 total filings